profit from every $100 of sales.
$0$100
HCA Healthcare
$499.05-0.32% today
+5.4% in 1 year
1-year low $361.321-year high $545.13
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
0%20% a year
You pay $15.37 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What HCA Healthcare sold, what it kept, and what it did with the cash.
Sales went from $60.2 billion in 2022 to $75.6 billion in 2025, with $6.78 billion of profit last year.
SalesProfit
HCA Healthcare handed back more cash to shareholders than it generated last year.
Buybacks $10.1B
Free cash flow 2025$7.7B
Bought back its own shares$10.1B
Paid as dividends$679M
Cash vs. debt$1.0B vs. $48.7B
HCA Healthcare vs. similar companies
HCA Healthcare grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| HCA Healthcare | 15.4× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.9× · Fair price | ||
 IHH Healthcare Berhad | 34.3× · Expensive | ||
 Rede D'Or São Luiz | 16.2× · Fair price | ||
 Apollo Hospitals Enterprise | 63.1× · Very expensive |
Compare HCA Healthcare with Tenet Healthcare
AI analysis
An AI analyst reads HCA Healthcare's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 51,533 | 58,752 | 60,233 | 64,968 | 70,603 | 75,600 | |
| – | – | 23,177 | 25,579 | 28,678 | 31,374 | |
| – | – | 9,053 | 9,627 | 10,547 | 11,965 | |
| 9,735 | 14,252 | 13,290 | 12,721 | 13,896 | 15,603 | |
| 3,754 | 6,956 | 5,643 | 5,242 | 5,760 | 6,784 | |
| 10.93 | 21.16 | 19.15 | 18.97 | 22.00 | 28.33 | |
| – | – | 38.5% | 39.4% | 40.6% | 41.5% | |
| – | – | 15.0% | 14.8% | 14.9% | 15.8% | |
| 7.3% | 11.8% | 9.4% | 8.1% | 8.2% | 9.0% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 47,490 | 50,742 | 52,438 | 56,211 | 59,513 | 60,720 |
| Cash | 1,793 | 1,451 | 908 | 935 | 1,933 | 1,040 |
| Total debt | – | – | 40,200 | 41,859 | 45,237 | 48,697 |
| Total liabilities | – | – | 52,511 | 55,151 | 58,958 | 63,491 |
| 572 | -933 | -2,767 | -1,774 | -2,499 | -6,027 | |
| 344 | 329 | 295 | 276 | 262 | 239 | |
| 968.7% | – | 21.8% | 19.0% | 19.6% | 22.4% | |
| 656.3% | -745.6% | -203.9% | -295.5% | -230.5% | -112.6% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 9,232 | 8,959 | 8,522 | 9,431 | 10,514 | 12,636 | |
| 2,835 | 3,577 | 4,395 | 4,744 | 4,875 | 4,944 | |
| 6,397 | 5,382 | 4,127 | 4,687 | 5,639 | 7,692 | |
| Dividends paid | 153 | 624 | 653 | 661 | 690 | 679 |
| 441 | 8,215 | 7,000 | 3,811 | 6,042 | 10,067 | |
| 362 | 440 | 341 | 262 | 360 | 401 |
Valuation
- 15.4×
- 16.5×
- 0.73
- -16.2×
- 1.4×
- 13.6×
- 9.7×
- 7.4%
- 6.5%
- 0.8%
Profitability
- 41.5%
- 15.8%
- 9.0%
- 20.5%
- 22.9%
- 21.2%
- -123.2%
- 11.1%
- 28.4%
- –
Growth
- +8.0%
- +21.0%
- +36.4%
- +30.2%
- −6.7%
Financial health
- 3.1×
- -8.08
- 81.1%
- 5.4×
- 0.97
- 0.75
- 1.24
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 6%of 946
Top 33%of 872
Top 20%of 563
Bottom 38%of 868
Top 11%of 986
What analysts expect
- Average price target
- $527.45
- Range
- $436.00 – $635.00
- 10 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 24, 2026 | 7.15 | 7.12 | +0.4% |
| Jan 27, 2026 | 8.01 | 7.46 | +7.4% |
| Oct 24, 2025 | 6.96 | 5.79 | +20.2% |
| Jul 25, 2025 | 6.84 | 6.29 | +8.7% |
| Apr 25, 2025 | 6.45 | 5.75 | +12.2% |
| Jan 24, 2025 | 6.22 | 6.13 | +1.5% |
| Oct 25, 2024 | 5.03 | 4.99 | +0.8% |
| Jul 23, 2024 | 5.53 | 4.85 | +14.0% |
0.8%of the share price, paid each year
On $1,000 invested$8a year at today's yield, before tax
+30.2%2020 to 2025
Raised5 yearsin a row, in our data
Paid per share, each year
$1.40 in 2018 → $2.88 in 2025
How safe it looks
10.0% of its profit
Room to growStretchedMore than it earns: 8.8%
News
Gabelli Healthcare & Wellness Trust raises dividend by 17.6% to $0.20Seeking Alpha · Nov 11, 2026Healthcare Just Hit a Record Lead Over Tech. 3 Things Could Shrink ItYahoo Finance · Nov 11, 2026Notable healthcare headlines for the week: Moderna, Pfizer, and CVS Health in focusSeeking Alpha · Nov 8, 2026The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?Yahoo Finance · Nov 7, 2026American Healthcare REIT forecasts $2.23-$2.26 2026 NFFO per share as same-store NOI growth target rises to 12%-14%Seeking Alpha · Nov 6, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
6/7Passes 6 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
66Pass
Benjamin Graham
70Pass
Philip Fisher
75Pass
Peter Lynch
74Pass
Joel Greenblatt
56No pass
Charlie Munger
65Pass
Terry Smith
63Pass
Questions about HCA Healthcare
Is HCA Healthcare a good stock to buy?
A business with weak numbers at a fair price. 6 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the HCA Healthcare AI analysis
What does HCA Healthcare do?
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. It is in Medical Care Facilities, based in Nashville, TN, United States, with 230,000 employees.
Does HCA Healthcare pay a dividend?
Yes. At today's price the dividend is 0.8% a year, about 10% of its yearly profit. In 2025 it paid out $679 million in dividends.
Is HCA Healthcare stock halal?
No. HCA Healthcare does not pass our halal screen: its debt is 47% of its market value, at or above the 33% limit. How we check
How has HCA Healthcare stock done over the past year?
Up 5.4% over the past twelve months, to $499.05. It traded between $361.32 and $545.13 and is 8.5% below its high.
Who are HCA Healthcare's competitors?
The largest listed companies in the same industry are Fresenius SE & Co. KGaA, IHH Healthcare Berhad, Rede D'Or São Luiz and Apollo Hospitals Enterprise. The peers table on this page compares their profit, growth and price with HCA Healthcare's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.